- Home
- VISN vs BCRX Comparison
VISN vs BCRX Comparison
Compare VISN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VISN | BCRX |
|---|---|---|
| Founded | 1976 | 1986 |
| Country | United States | United States |
| Employees | 4500 | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.4B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | VISN | BCRX |
|---|---|---|
| Price | $11.46 | $9.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $21.00 | $20.82 |
| AVG Volume (30 Days) | ★ 6.9M | 3.3M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,186,000.00 |
| Revenue This Year | $9.44 | N/A |
| Revenue Next Year | $5.91 | $12.55 |
| P/E Ratio | $5.37 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.47 | $6.00 |
| 52 Week High | $19.91 | $11.22 |
Technical Indicators
Market Signals| Indicator | VISN | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.60 | 56.61 |
| Support Level | $11.44 | $8.80 |
| Resistance Level | $12.80 | $9.90 |
| Average True Range (ATR) | 0.45 | 0.38 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 56.19 | 90.00 |
Price Performance
Historical ComparisonAbout VISN Vistance Networks Inc. Common Stock
Vistance Networks Inc operates in the communications technology sector, providing solutions designed to support the delivery and management of communications services. It serves customers globally through teams involved in product development, implementation, and customer support. The company designs and develops network infrastructure and connectivity solutions focused on reliability and performance. Its offerings include intelligent networking technologies intended to support evolving communication requirements.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.